Literature DB >> 18566018

Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.

Nicola Machella1, Mary Beth Terry, Jennifer Zipprich, Irina Gurvich, Yuyan Liao, Ruby T Senie, David O Kennedy, Regina M Santella.   

Abstract

Unrepaired DNA double-strand breaks (DSBs) may have serious consequences for cells by inducing chromosomal aberrations, thereby increasing genetic instability and cancer risk. One's capacity to repair DSB is therefore an important factor to consider when estimating cancer risk. We assessed DNA end-joining (EJ) capacity in cell lines derived from sisters discordant for breast cancer to determine if individual differences in DSB repair are a significant risk factor. We used an in vitro phenotypic assay on nuclear extracts from lymphoblasts of 179 subjects including 86 cases and 93 controls. EJ activity was functionally estimated as the ability of extracts to join together monomers of the plasmid pUC18 linearized either with sticky (EcoRI) or blunt ends (HincII). Mean percentage of EJ capacity was slightly lower in cases than controls, both for EcoRI (cases 27.9 +/- 11.1; controls 29.6 +/- 10.7, P = 0.28) and HincII substrates (cases 28.8 +/- 12.2; controls 30.6 +/- 13.0, P = 0.36); however, no significant differences were observed. Categorizing EJ capacity into tertiles and using the highest activity as the referent, we observed elevated associations for each tertile of decreased repair [Odds ratio (OR) = 2.20, 95% confidence interval (CI) = 0.77-6.22 and OR = 4.22, 95% CI thinsp;= 1.22-14.0, P = 0.02], respectively, for EcoRI. Results were not statistically significant for HincII (OR = 1.37, 95% CI = 0.51-3.70 and OR = 2.32, 95% CI = 0.57-9.38, P = 0.24). These data suggest that individual differences in EJ capacity may represent a risk factor predisposing women to breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566018      PMCID: PMC2899852          DOI: 10.1093/carcin/bgn140

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  47 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

2.  Increased error-prone non homologous DNA end-joining--a proposed mechanism of chromosomal instability in Bloom's syndrome.

Authors:  Terry J Gaymes; Phillip S North; Nicola Brady; Ian D Hickson; Ghulam J Mufti; Feyruz V Rassool
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

3.  Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies.

Authors:  J C Beck; C M Beiswanger; E M John; E Satariano; D West
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

4.  Variants in DNA double-strand break repair genes and breast cancer susceptibility.

Authors:  Bettina Kuschel; Annika Auranen; Simon McBride; Karen L Novik; Antonis Antoniou; Julian M Lipscombe; Nicholas E Day; Douglas F Easton; Bruce A J Ponder; Paul D P Pharoah; Alison Dunning
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

5.  Measuring DNA repair capacity: small steps.

Authors:  Marianne Berwick; Paolo Vineis
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

6.  Processing of DNA for nonhomologous end-joining by cell-free extract.

Authors:  Joe Budman; Gilbert Chu
Journal:  EMBO J       Date:  2005-02-03       Impact factor: 11.598

7.  Interrogating DNA repair in cancer risk assessment.

Authors:  Tamar Paz-Elizur; Dean E Brenner; Zvi Livneh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

8.  DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.

Authors:  David O Kennedy; Meenakshi Agrawal; Jing Shen; Mary Beth Terry; Fang Fang Zhang; Ruby T Senie; Grazyna Motykiewicz; Regina M Santella
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

9.  In vitro repair of complex unligatable oxidatively induced DNA double-strand breaks by human cell extracts.

Authors:  E Pastwa; R D Neumann; T A Winters
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

Review 10.  Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review.

Authors:  M Berwick; P Vineis
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

View more
  21 in total

1.  Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.

Authors:  Maya Kappil; Mary Beth Terry; Lissette Delgado-Cruzata; Yuyan Liao; Regina M Santella
Journal:  Anticancer Res       Date:  2016-09       Impact factor: 2.480

2.  Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

Authors:  Zachary D Nagel; Isaac A Chaim; Leona D Samson
Journal:  DNA Repair (Amst)       Date:  2014-04-26

Review 3.  Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.

Authors:  Anna Csiszar; Priya Balasubramanian; Stefano Tarantini; Andriy Yabluchanskiy; Xin A Zhang; Zsolt Springo; Doris Benbrook; William E Sonntag; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-04-29       Impact factor: 7.713

4.  Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.

Authors:  Lissette Delgado-Cruzata; Hui-Chen Wu; Mary Perrin; Yuyan Liao; Maya A Kappil; Jennifer S Ferris; Julie D Flom; Hulya Yazici; Regina M Santella; Mary Beth Terry
Journal:  Epigenetics       Date:  2012-06-18       Impact factor: 4.528

Review 5.  Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.

Authors:  Zachary D Nagel; Bevin P Engelward; David J Brenner; Thomas J Begley; Robert W Sobol; Jason H Bielas; Peter J Stambrook; Qingyi Wei; Jennifer J Hu; Mary Beth Terry; Caroline Dilworth; Kimberly A McAllister; Les Reinlib; Leroy Worth; Daniel T Shaughnessy
Journal:  Mutat Res       Date:  2017-04-06       Impact factor: 2.433

6.  XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study.

Authors:  Jennifer Zipprich; Mary Beth Terry; Paul Brandt-Rauf; Greg A Freyer; Yuyan Liao; Meenakshi Agrawal; Irina Gurvich; Ruby Senie; Regina M Santella
Journal:  J Carcinog       Date:  2010-04-16

7.  DNA Repair Gene Expression Levels as Indicators of Breast Cancer in the Breast Cancer Family Registry.

Authors:  Maya A Kappil; Yuyan Liao; Mary Beth Terry; Regina M Santella
Journal:  Anticancer Res       Date:  2016-08       Impact factor: 2.480

8.  Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.

Authors:  Li-E Wang; Olga Y Gorlova; Jun Ying; Yawei Qiao; Shih-Feng Weng; Annette T Lee; Peter K Gregersen; Margaret R Spitz; Christopher I Amos; Qingyi Wei
Journal:  Cancer Res       Date:  2012-10-29       Impact factor: 12.701

9.  DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR).

Authors:  Hui-Chen Wu; Lissette Delgado-Cruzata; Nicola Machella; Qiao Wang; Regina M Santella; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2013-09-24       Impact factor: 2.506

10.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer.

Authors:  Ji-Yeob Choi; Smitha R James; Petra A Link; Susan E McCann; Chi-Chen Hong; Warren Davis; Mary K Nesline; Christine B Ambrosone; Adam R Karpf
Journal:  Carcinogenesis       Date:  2009-07-07       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.